Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Jankovic, Ljiljana (7006253631)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Prevalence of oral herpes simplex virus reactivation in cancer patients: A comparison of different techniques of viral detection
    (2009)
    Djuric, Milanko (8838562400)
    ;
    Jankovic, Ljiljana (7006253631)
    ;
    Jovanovic, Tanja (26642921700)
    ;
    Pavlica, Dusan (15849034500)
    ;
    Brkic, Snezana (58119094400)
    ;
    Knezevic, Aleksandra (22034890600)
    ;
    Markovic, Dubravka (7004487104)
    ;
    Milasin, Jelena (6603015594)
    Background: Oral reactivation of latent Herpes simplex virus (HSV) infection may easily occur in cancer patients. Virus reactivation can cause oral mucosa damage, worsen already existing lesions caused by stomatotoxic effect of cancer therapy and, whether symptomatic or asymptomatic, ample spreading and promote viral transmission. Methods: Polymerase chain reaction (PCR), cell-culture and direct immunofluorescence have been used to determine the frequency of oral HSV reactivation in 60 patients undergoing chemotherapy for different malignancies. Results: By means of PCR, the presence of viral DNA was detected in 71.7% of patients prior to chemotherapy and in 85.0% after chemotherapy. 33.3% of patients before and 40.0% after chemotherapy were viral-culture positive, while 3.3% of patients before and 11.7% after chemotherapy were positive as shown by direct immunofluorescence. No significant difference in HSV-1 reactivation was found before and after chemotherapy. In addition, no significant difference was found when comparing HSV-1 reactivation in patients with and without mucositis. HSV-2 was not detected in any of the patients. Conclusions: Reactivation of latent HSV is exceptionally frequent in cancer patients. The results of this study suggest that virus reactivation occurs independently of cancer chemotherapy. The potential role of HSV reactivation in oral mucosa damage remains unclear. © 2008 Blackwell Munksgaard.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Prevalence of oral herpes simplex virus reactivation in cancer patients: A comparison of different techniques of viral detection
    (2009)
    Djuric, Milanko (8838562400)
    ;
    Jankovic, Ljiljana (7006253631)
    ;
    Jovanovic, Tanja (26642921700)
    ;
    Pavlica, Dusan (15849034500)
    ;
    Brkic, Snezana (58119094400)
    ;
    Knezevic, Aleksandra (22034890600)
    ;
    Markovic, Dubravka (7004487104)
    ;
    Milasin, Jelena (6603015594)
    Background: Oral reactivation of latent Herpes simplex virus (HSV) infection may easily occur in cancer patients. Virus reactivation can cause oral mucosa damage, worsen already existing lesions caused by stomatotoxic effect of cancer therapy and, whether symptomatic or asymptomatic, ample spreading and promote viral transmission. Methods: Polymerase chain reaction (PCR), cell-culture and direct immunofluorescence have been used to determine the frequency of oral HSV reactivation in 60 patients undergoing chemotherapy for different malignancies. Results: By means of PCR, the presence of viral DNA was detected in 71.7% of patients prior to chemotherapy and in 85.0% after chemotherapy. 33.3% of patients before and 40.0% after chemotherapy were viral-culture positive, while 3.3% of patients before and 11.7% after chemotherapy were positive as shown by direct immunofluorescence. No significant difference in HSV-1 reactivation was found before and after chemotherapy. In addition, no significant difference was found when comparing HSV-1 reactivation in patients with and without mucositis. HSV-2 was not detected in any of the patients. Conclusions: Reactivation of latent HSV is exceptionally frequent in cancer patients. The results of this study suggest that virus reactivation occurs independently of cancer chemotherapy. The potential role of HSV reactivation in oral mucosa damage remains unclear. © 2008 Blackwell Munksgaard.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers
    (2013)
    Besu, Irina (34567735200)
    ;
    Jankovic, Ljiljana (7006253631)
    ;
    Konic-Ristic, Aleksandra (15019275900)
    ;
    Raskovic, Sanvila (6602461528)
    ;
    Besu, Valeri (55341986500)
    ;
    Djuric, Milanko (8838562400)
    ;
    Cakic, Sasa (25226761500)
    ;
    Magdu, Ileana Ursu (35315770800)
    ;
    Juranic, Zorica (7003932917)
    Background: Recurrent aphthous ulcerations (RAU), or recurrent aphthous stomatitis, is recognized as one of the most common oral mucosal diseases worldwide. It was noted some connection between immunity to cow's milk proteins (CMP) and oral diseases. The goal of this study was to determine the prevalence of the increased levels of serum antibodies to specific cow's milk proteins (SCMP), constituents of cheese or of whey, by enzyme-linked immunosorbent assay (ELISA) test, in subjects who have RAU. Methods: Fifty subjects with RAU and 50 healthy people, as controls (C), were included in this research. Levels of serum IgA, IgG, and IgE antibodies to SCMP were determined by ELISA. The statistical analysis of data was performed by Wilcoxon rank sum test with continuity correction. Results: The levels of serum anti-SCMP IgA, IgG, and IgE antibodies were significantly higher in subjects with RAU in comparison with controls (P < 0.005). Conclusions: These results indicate the strong association between high levels of serum anti-SCMP IgA, IgG, and IgE antibodies, especially to caseins: α-, β-, and κ-casein from cow's milk and clinical manifestations of RAU. Serum immunity to the whey proteins in subjects with RAU was not in so high percentage expressed. © 2012 John Wiley & Sons A/S.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers
    (2013)
    Besu, Irina (34567735200)
    ;
    Jankovic, Ljiljana (7006253631)
    ;
    Konic-Ristic, Aleksandra (15019275900)
    ;
    Raskovic, Sanvila (6602461528)
    ;
    Besu, Valeri (55341986500)
    ;
    Djuric, Milanko (8838562400)
    ;
    Cakic, Sasa (25226761500)
    ;
    Magdu, Ileana Ursu (35315770800)
    ;
    Juranic, Zorica (7003932917)
    Background: Recurrent aphthous ulcerations (RAU), or recurrent aphthous stomatitis, is recognized as one of the most common oral mucosal diseases worldwide. It was noted some connection between immunity to cow's milk proteins (CMP) and oral diseases. The goal of this study was to determine the prevalence of the increased levels of serum antibodies to specific cow's milk proteins (SCMP), constituents of cheese or of whey, by enzyme-linked immunosorbent assay (ELISA) test, in subjects who have RAU. Methods: Fifty subjects with RAU and 50 healthy people, as controls (C), were included in this research. Levels of serum IgA, IgG, and IgE antibodies to SCMP were determined by ELISA. The statistical analysis of data was performed by Wilcoxon rank sum test with continuity correction. Results: The levels of serum anti-SCMP IgA, IgG, and IgE antibodies were significantly higher in subjects with RAU in comparison with controls (P < 0.005). Conclusions: These results indicate the strong association between high levels of serum anti-SCMP IgA, IgG, and IgE antibodies, especially to caseins: α-, β-, and κ-casein from cow's milk and clinical manifestations of RAU. Serum immunity to the whey proteins in subjects with RAU was not in so high percentage expressed. © 2012 John Wiley & Sons A/S.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback